Age-related decrease in adenovirus-specific T cell responses

Martina Sester1, Urban Sester, Susana Alarcon Salvador

  • 1Medical Department IV, Institute of Medical Microbiology and Hygiene, University of the Saarland, Homburg, Germany. martha.sester@uniklinik-saarland.de

Insights

Adenovirus immunity relies on CD4 T cells. Its decline with age may explain why younger transplant patients face more adenovirus complications, unlike older adults.

Area of Science:

  • Immunology
  • Virology
  • Transplantation

Background:

  • Persistent viral infections like adenovirus can cause severe issues in immunocompromised individuals.
  • The cellular immune response is crucial for controlling viral replication, as seen with cytomegalovirus (CMV).
  • Human cellular immunity to adenoviruses remains incompletely understood.

Purpose of the Study:

  • To quantitatively and functionally analyze adenovirus-specific T cell responses.
  • To compare immune responses in healthy individuals and renal transplant recipients.
  • To investigate the role of T cells in adenovirus immunity.

Main Methods:

  • Flow-cytometric assays
  • Standard proliferation assays
  • Enzyme-linked immunosorbent assays (ELISA)
  • Analysis of 171 healthy individuals and 59 renal transplant recipients.

Main Results:

  • Adenovirus-specific immunity is primarily mediated by CD4 T cells with a memory/effector phenotype.
  • The frequency of adenovirus-specific T cells significantly decreases with increasing age.
  • This age-related decline suggests a potential lifetime clearance of adenoviruses.

Conclusions:

  • Adenovirus-specific T cell responses are characterized by CD4 T cells.
  • The decline in adenovirus-specific T cells with age may underlie the higher incidence of complications in younger transplant patients.
  • Understanding these immune dynamics is vital for managing adenovirus infections in vulnerable populations.